Ir para o menu de navegação principal Ir para o conteúdo principal Ir para o rodapé

Use of infliximab in patient with chronic non-bacterial osteomyelitis, case report




Seção
Artículos de Reportes de Caso

Como Citar
Longo, B., Ferroni Tonial, A. ., & Skare, T. (2019). Use of infliximab in patient with chronic non-bacterial osteomyelitis, case report. Archivos De Medicina , 19(1), 168-172. https://doi.org/10.30554/archmed.19.1.2618.2019
Baixar Citação

Dimensions
PlumX

Como Citar

Longo, B., Ferroni Tonial, A. ., & Skare, T. (2019). Use of infliximab in patient with chronic non-bacterial osteomyelitis, case report. Archivos De Medicina , 19(1), 168-172. https://doi.org/10.30554/archmed.19.1.2618.2019

Baixar Citação

##articleSummary.license##
Betânia Longo
Alessandro Ferroni Tonial
Thelma Skare

Betânia Longo,

[1] MD, rheumatology resident. Evangelic University Hospital, Curitiba, PR, Brazil.


Alessandro Ferroni Tonial,

MD, rheumatology resident. Evangelic University Hospital, Curitiba, PR, Brazil.


Thelma Skare,

MD, PhD. Head of Rheumatology Unit. Evangelic University Hospital, Curitiba, PR, Brazil.


Introduction: chronic non-bacterial osteomyelitis (CNO) is a non-infectious inflammatory of unknown etiology. Case description: ABA, female, 16 years old, was admitted with a pain in her left thigh. At the time, it was suspected to be caused by a tumor, and a bone scintigraphy was requested, which evidenced a focal area of increased uptake in the distal metadiaphyseal area of the left femur. A bone biopsy was performed, and its result was compatible with chronic osteomyelitis. The patient started taking pamidronate (withdrawn due to treatment failure) and methotrexate (subsequently suspended due to urticarial reaction). After some years of clinical stability, a new focal area of osteomyelitis appeared, in the distal right femur. The use of anti-TNF (infliximab) was chosen, resulting in an improvement of the algic state. Discussion: the diagnosis of CNO is made by process of elimination and is based on clinical, laboratorial, radiological, bacteriological and histological data. Non-hormonal anti-inflammatory and bisphosphonate drugs are recommended as initial therapy. Disease-modifying drugs, steroids and anti-TNFα have been used in severe and recurring cases. Conclusion: the authors present a CNO case with good response to anti-TNFα after treatment failure with bisphosphonates.


Visão geral 582 | Visualizações de PDF 55


Downloads

Os dados de download ainda não estão disponíveis.
Sistema OJS 3.4.0.10 - Metabiblioteca |